The Future of Opioid Use Disorder Treatment

Shaheen: My background is all about data. I could probably do one of these a month and we'd never catch up to what the patient's taking place. We just launched a phase three study into negative symptoms of schizophrenia. It's recruiting right now, patients with this disease can actually get access to our investigational device. If positive, we'll submit for approval and we could potentially be the first treatment ever for this disease.